Mantle cell lymphoma—Update on molecular biology, prognostication and treatment approaches
Hematological Oncology · 2023-06 · 41 (S1) · 36-42
DOI: 10.1002/hon.3149 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematological Oncology, online erschienen am 09.06.2023. Verfasst von Elisabeth Silkenstedt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, LMU University Hospital, Munich, Germany. Hauptthemen laut MEDLINE: Lymphoma, Mantle-Cell. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Mantle cell lymphoma (MCL) is clinically characterized by its heterogenous behavior with courses ranging from indolent cases that do not require therapy for years to highly aggressive MCL with very limited prognosis. The development and implementation of new targeted and immunotherapeutic approaches have already improved therapeutic options especially for refractory or relapsed disease. Nevertheless, to further optimize MCL treatment, early identification of individual risk profile and risk‐adapted, patient‐tailored choice of therapeutic strategy needs to be prospectively incorporated in clinical patient management. This review summarizes the current knowledge and standard of care regarding biology and clinical management of MCL, highlighting the implementation of new therapeutic approaches especially targeting the immune system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine III, LMU University Hospital, Munich, Germany.
Zitieren
APA
Silkenstedt, E., & Dreyling, M. (2023). Mantle cell lymphoma—Update on molecular biology, prognostication and treatment approaches. Hematological Oncology, 41(S1), 36-42. https://doi.org/10.1002/hon.3149
Vancouver
Silkenstedt E, Dreyling M. Mantle cell lymphoma—Update on molecular biology, prognostication and treatment approaches. Hematological Oncology. 2023;41(S1):36-42. doi:10.1002/hon.3149
BibTeX
@article{Silkenstedt2023,
author = {Silkenstedt, Elisabeth and Dreyling, Martin},
title = {Mantle cell lymphoma—Update on molecular biology, prognostication and treatment approaches},
journal = {Hematological Oncology},
year = {2023},
volume = {41},
number = {S1},
pages = {36--42},
doi = {10.1002/hon.3149}
}
EUVIMED